all report title image

GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Clinical Laboratory Tests Market is Segmented By Test Type (Complete Blood Count, Hgb/ Hct Testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, Hba1c Testing, Comprehensive Metabolic Panel, Liver Panel Testing, Renal Panel Testing, Lipid Panel Testing, Others), By Application (Parasitology, Virology, Hematology, Toxicology, Immunology/serology, Histopathology And Urinalysis), By End User (Central Laboratories, Hospital Laboratories, Independent Laboratories, Research and Academia), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published In : Jan 2024
  • Code : CMI6546
  • Pages :172
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Challenges And Opportunities

Restraints

  • Shortage of trained laboratory professionals: Shortfall of competent laboratory technologists and technicians those who are capable of operating advanced diagnostic systems remains a key bottleneck in the clinical laboratory testing industry. As the testing landscape evolves with new technologies, there is a growing need for continuously skilled professionals who can validate, optimize, troubleshoot, and support complex instrumentation. However, recruitment and retention of qualified lab staff have been challenging due to inadequate educational infrastructure, non-competitive salaries, and evolving job roles. According to the Bureau of Labor Statistics, the demand for clinical laboratory professionals is projected to rise 14% during the 2020–2030 decade, much faster than average growth for other healthcare occupations. But the current supply is insufficient to meet this projected need. The skills gap acts as a deterrent to optimizing lab capacity utilization and introduction of new assays to the market.

Global Clinical Laboratory Tests Market- Drivers

  • Rising burden of chronic diseases: With increasingly sedentary lifestyles and unhealthy eating habits becoming prevalent across the world, chronic diseases have been on a rise over the past few decades. Chronic conditions like cancer, cardiovascular diseases, diabetes, and others have emerged as the leading causes of mortality and reduced quality of life in majority of the countries. These diseases require long term medical supervision and a series of laboratory tests to monitor the condition of patients and assess treatment effectiveness over time. Rising cases of chronic diseases directly translate to increased demand for clinical pathology tests from hospitals and diagnostic laboratories. More tests mean more business and revenues for labs. Even developing nations are experiencing growing rates of non-communicable diseases as rates of urbanization increase and traditional diets change. This growing chronic disease burden faced by healthcare systems globally is a key driver positively impacting the clinical laboratory tests market.
  • Increasing aging population is driving demand for clinical laboratory tests : The aging population is one of the key drivers of growth in the clinical laboratory tests market. As people age, they naturally become more susceptible to various chronic diseases such as cancer, diabetes, heart disease, and respiratory diseases. Regular clinical testing helps in early detection and timely treatment of diseases, which is crucial for the elderly population. According to the U.S. Census Bureau, the population aged 65 years and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. The growing geriatric population will fuel the demand for preventive healthcare services including various laboratory tests for conditions monitoring in this demographic.

Global Clinical Laboratory Tests Market- Opportunities

  • Advancement of Clinical Laboratory Tests: Technological advancements are expanding the capabilities of clinical laboratory testing and driving the market growth. New diagnostic platforms like next-generation sequencing (NGS), mass spectrometry, microfluidics, and lab-on-a-chip systems are enhancing test menus, automation, speed, affordability, and accuracy. For instance, In November 2022, NGS has enabled multi-gene panel tests for conditions like cancer that can detect hundreds of genetic mutations simultaneously. Transition to digital pathology through whole slide imaging systems is allowing remote consultations and more efficient disease diagnosis. Continuous innovations in diagnostic technologies will lead to development of novel test types and assays, personalized medicine approaches, point-of-care testing solutions, and integrated diagnostic systems. This will increase clinical testing utilization and frequency across various healthcare settings.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.